Glycogen Storage Disease Type III clinical trials at UC Irvine

• Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)

  open to eligible people ages 5-65

  The primary objective of this study is to evaluate potential biomarkers of GSD III.

  Irvine, California and other locations

Last updated: January 4, 2021